跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,946 条关于
“ImpriMed”
全部
1,946
临床试验
1,776
药物
7
机构
5
资讯
158
去年
AI-Powered Drug Response Prediction Shows Promise in Human Blood Cancers
去年
Comparative Oncology Breakthrough: How Pet Dogs Are Advancing Human Cancer Treatment
去年
Luspatercept and Novel Therapies Reshape Treatment Strategies in Myelodysplastic Syndromes
去年
Relacorilant and Surgery Improve Hemostatic Markers in Cushing's Syndrome
去年
Newer Antiseizure Medications Show Improved Safety Profile During Pregnancy
去年
NIAGARA Trial: Durvalumab Plus Chemotherapy Improves Survival in Bladder Cancer
2年前
Durvalumab Demonstrates Improved Survival in Liver and Bladder Cancers
去年
Elafibranor Demonstrates Improved Transplant-Free Survival in PBC Patients
去年
SEL-212 Demonstrates Improved Outcomes in Refractory Gout Patients
去年
Momelotinib Demonstrates Improved Overall Survival in Ruxolitinib-Pretreated Myelofibrosis
第 1 页,共 16 页
上一页
下一页